Legislation changes for controlled drugs
15th April 2015
Several legislation changes to the Misuse of Drugs Regulations 2001 have been approved by Parliament for England, Scotland and Wales, resulting in changes in practice on 1st June 2015 and 30th November 2015. Those most relevant to palliative care include:
1st June 2015
- temazepam prescriptions will now be required to meet full prescription requirements for Schedule 2 and 3 CDs
- electronic prescribing of Schedule 2 and 3 CDs will be permitted where the Electronic Prescribing System (EPS) is used
- physiotherapist independent prescribers will be able to prescribe the following CDs for the treatment of organic disease or injury:
- PO diazepam, dihydrocodeine, lorazepam, morphine, oxycodone, temazepam
- TD fentanyl
- morphine by injection
- chiropodist/podiatrist independent prescribers will be able to prescribe the following CDs for the treatment of organic disease or injury:
- PO diazepam, dihydrocodeine, lorazepam, temazepam.
30th November 2015
- ketamine will become a Schedule 2 CD (with exemptions for specific health professionals under Patient Group Directions)
- Standardised requisition forms for Schedule 1, 2 and 3 CDs will become mandatory. Hospices and prisons will be exempt.
Other changes involve the emergency supply of phenobarbital, authority for NHS Ambulance Trusts to possess and supply CDs, authority to supply CDs in prisons, midwife supply orders, paramedic and operating department practitioner stock requisition.
- FDA approves 2mg naloxone nasal spray
- Gabapentin oral solution and enteral feeding tubes
- Cochrane review: fentanyl for neuropathic pain
- Cochrane review: hydromorphone for cancer pain
- Cochrane review: benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases
- End of life care for infants, children and young people with life-limiting conditions: planning and management
- Calling all members - please complete our satisfaction survey!
- pH testing for nasogastric tube positioning is cost effective
- Hydromorphone injection now authorized in the UK
- Patient Safety Alert: Risk of death and severe harm from error with injectable phenytoin